default author photo

Byoung Chul Cho

Yonsei University - Yonsei Cancer Center

Seoul

Korea, Republic of (South Korea)

  • Yonsei University - Yonsei Cancer Center

SCHOLARLY PAPERS

4

DOWNLOADS

203

TOTAL CITATIONS

0

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Tiragolumab Plus Atezolizumab Versus Placebo Plus Atezolizumab in Patients with Previously Untreated PD-L1-High, Locally Advanced Unresectable or Metastatic NSCLC (SKYSCRAPER-01): A Phase 3, Randomised, Double-Blind, Placebo-Controlled Study

Number of pages: 36 Posted: 19 Sep 2025
solange peters, Roy Herbst, Hidehito Horinouchi, Luis Paz Ares, Melissa Johnson, Benjamin J. Solomon, Mahmut Gumus, Mustafa Erman, Igor Bondarenko, Dong-Wan Kim, Enriqueta Felip, Alessandro Morabito, Maciej Bryl, Urbán László, Kaname Nosaki, Martin Reck, Raymond Meng, Chipman Stroud, Palak Kundu, Xiaohui Wen, Namrata S. Patil, Meilin Huang, Sarah Troutman, Christina Matheny and Byoung Chul Cho
Centre Hospitalier Universitaire Vaudois (CHUV), Yale University, National Cancer Center Hospital, University Hospital 12 de Octubre, Sarah Cannon Research Institute, Peter MacCallum Cancer Centre, Istanbul Medeniyet University, Hacettepe University, Dniprovsky State Medical University, Seoul National University - Department of Internal Medicine, Hospital Vall d’Hebron, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale, E.J. Zeyland Wielkopolska Center of Pulmonology and Thoracic Surgery, Matrahaza University, National Cancer Center Hospital East, German Centre for Lung Research - Lungen Clinic Grosshansdorf, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco and Yonsei University - Yonsei Cancer Center
Downloads 82 (790,029)

Abstract:

Loading...

Non-small cell lung cancer, NSCLC, immune checkpoint inhibitors, anti-TIGIT monoclonal antibody, PD-L1 inhibitor, atezolizumab, tiragolumab, cancer immunotherapy

2.

Lazertinib in Pretreated EGFR T790M-Mutated Advanced Non-Small Cell Lung Cancer: A Real-World Multicenter Study

Number of pages: 22 Posted: 15 Mar 2023
Hyunwook Kim, Beung-Chul Ahn, Jiyun Lee, Jii Bum Lee, Min-Hee Hong, Hye Ryun Kim, Byoung Chul Cho and Sun Min Lim
Yonsei University - Yonsei Cancer Center, Yonsei University - Yonsei Cancer Center, Yonsei University - Yonsei Cancer Center, Yonsei University - Yonsei Cancer Center, Yonsei University - Yonsei Cancer Center, Yonsei University - Yonsei Cancer Center, Yonsei University - Yonsei Cancer Center and Yonsei University - Yonsei Cancer Center
Downloads 56 (1,000,027)

Abstract:

Loading...

Lazertinib, real-world data, T790M EGFR mutation, non-small cell lung cancer

3.

Novel Allosteric Glutaminase 1 Inhibitors with Macrocyclic Structure Activity Relationship Analysis

Number of pages: 15 Posted: 23 Jun 2022
Eun Ji Lee, Krishna Babu Duggirala, Yujin Lee, Mi Ran Yun, Jiyoon Jang, Rajath Cyriac, Myoung Eun Jung, Gildon Choi, Chong Hak Chae, Byoung Chul Cho and Kwangho Lee
Yonsei University - College of Medicine, Korea Research Institute of Chemical Technology (KRICT) - Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology (KRICT) - Bio & Drug Discovery Division, Yonsei University - College of Medicine, Korea Research Institute of Chemical Technology (KRICT) - Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology (KRICT) - Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology (KRICT) - Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology (KRICT) - Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology (KRICT) - Bio & Drug Discovery Division, Yonsei University - Yonsei Cancer Center and Korea Research Institute of Chemical Technology (KRICT) - Bio & Drug Discovery Division
Downloads 42 (1,157,785)

Abstract:

Loading...

glutaminase 1, GLS1, macrocycle, anticancer, KRAS, KEAP1, BPTES, cancer metabolism

4.

Association of Thyroid Radiation Dose with Thyroid Dysfunction in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy Followed by Maintenance Immunotherapy

Number of pages: 25 Posted: 06 Mar 2025
Gowoon Yang, Hong In Yoon, Sun Min Lim, Min-Hee Hong, Jaeho Cho, Chang Geol Lee, Byoung Chul Cho, Hye Ryun Kim and Kyung Hwan Kim
affiliation not provided to SSRN, Yonsei University - Yonsei Cancer Center, Yonsei University - Yonsei Cancer Center, Yonsei University - Yonsei Cancer Center, Yonsei University - Yonsei Cancer Center, affiliation not provided to SSRN, Yonsei University - Yonsei Cancer Center, Yonsei University - Yonsei Cancer Center and affiliation not provided to SSRN
Downloads 23 (1,411,822)

Abstract:

Loading...

Carcinoma, Non-Small Cell Lung, radiotherapy, Immunotherapy, Hypothyroidism